Use of Purified Clostridium difficile Spores To Facilitate Evaluation of Health Care Disinfection Regimens

被引:87
|
作者
Lawley, Trevor D. [1 ]
Clare, Simon [1 ]
Deakin, Laura J. [1 ]
Goulding, David [1 ]
Yen, Jennifer L. [1 ]
Raisen, Claire [1 ]
Brandt, Cordelia [1 ]
Lovell, Jon [1 ]
Cooke, Fiona [4 ]
Clark, Taane G. [2 ,3 ]
Dougan, Gordon [1 ]
机构
[1] Wellcome Trust Sanger Inst, Microbial Pathogenesis Lab, Hinxton CB10 1SA, Cambs, England
[2] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1E 7HT, England
[3] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
[4] Addenbrookes Hosp, Dept Microbiol, Cambridge CB2 2QQ, England
基金
英国惠康基金;
关键词
HYDROGEN-PEROXIDE VAPOR; ENVIRONMENTAL CONTAMINATION; HYPOCHLORITE SOLUTION; INFECTION; TRANSMISSION; EPIDEMIC; DISEASE; TYPHIMURIUM; RESISTANCE; EFFICACY;
D O I
10.1128/AEM.00718-10
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Clostridium difficile is a major cause of antibiotic-associated diarrheal disease in many parts of the world. In recent years, distinct genetic variants of C. difficile that cause severe disease and persist within health care settings have emerged. Highly resistant and infectious C. difficile spores are proposed to be the main vectors of environmental persistence and host transmission, so methods to accurately monitor spores and their inactivation are urgently needed. Here we describe simple quantitative methods, based on purified C. difficile spores and a murine transmission model, for evaluating health care disinfection regimens. We demonstrate that disinfectants that contain strong oxidizing active ingredients, such as hydrogen peroxide, are very effective in inactivating pure spores and blocking spore-mediated transmission. Complete inactivation of 10(6) pure C. difficile spores on indicator strips, a six-log reduction, and a standard measure of stringent disinfection regimens require at least 5 min of exposure to hydrogen peroxide vapor (HPV; 400 ppm). In contrast, a 1-min treatment with HPV was required to disinfect an environment that was heavily contaminated with C. difficile spores (17 to 29 spores/cm(2)) and block host transmission. Thus, pure C. difficile spores facilitate practical methods for evaluating the efficacy of C. difficile spore disinfection regimens and bringing scientific acumen to C. difficile infection control.
引用
收藏
页码:6895 / 6900
页数:6
相关论文
共 50 条
  • [21] Implications of the changing face of Clostridium difficile disease for health care practitioners
    McFarland, Lynne V.
    Beneda, Henry W.
    Clarridge, Jill E.
    Raugi, Gregory J.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2007, 35 (04) : 237 - 253
  • [22] The Epidemiology of Clostridium difficile Infection Inside and Outside Health Care Institutions
    Gerding, Dale N.
    Lessa, Fernanda C.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2015, 29 (01) : 37 - +
  • [23] Clostridium difficile Infections in Veterans Health Administration Acute Care Facilities
    Evans, Martin E.
    Simbartl, Loretta A.
    Kralovic, Stephen M.
    Jain, Rajiv
    Roselle, Gary A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (08): : 1037 - 1042
  • [24] Laboratory plasticware - Use at your own risk: Suitability of microcentrifuge tubes for spores, analysis of Clostridium difficile
    Broukhanski, G.
    Budylowski, R.
    ANAEROBE, 2019, 55 : 61 - 66
  • [25] Evaluation of peracetic acid sporicidal wipes in removing Clostridioides (Clostridium) difficile spores from rubber surfaces
    Lim, S. C.
    Collins, D.
    Riley, T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 312 - 312
  • [26] Evaluation of the Use of Rectal Swabs for Laboratory Diagnosis of Clostridium difficile Infection
    Jazmati, N.
    Kirpal, E.
    Piepenbrock, E.
    Stelzer, Y.
    Vehreschild, M. J. G. T.
    Seifert, H.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (07)
  • [27] Crohn's Disease, Antibiotic Use, and Recent Health Care Exposures Are Associated with Clostridium difficile Isolation in IBD
    Micic, Dejan
    Gaetano, John N.
    Gonsalves, Alex
    Broadaway, Susan
    Hirsch, Ayal
    Yarur, Andres
    Cohen, Russell
    Dalal, Sushila
    Pekow, Joel
    Sakuraba, Atsushi
    Walk, Seth
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S270 - S271
  • [28] Fluoroquinolone use and risk factors for Clostridium difficile -: Associated disease within a veterans administration health care system
    McFarland, Lynne V.
    Clarridge, Jill E.
    Beneda, Henry W.
    Raugi, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (09) : 1141 - 1151
  • [29] Clostridium difficile infection among health care workers receiving antibiotic therapy
    Arfons, L
    Ray, AJ
    Donskey, CJ
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) : 1384 - 1385
  • [30] Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile
    Kyne, L
    Hamel, MB
    Polavaram, R
    Kelly, CNP
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) : 346 - 353